SV2A and idiopathic generalized epilepsy: Therefore, In the current study, we investigated the regulatory influence of the 21‐day treatment of probiotic supplementation as an add‐on therapy with BRV, an SV2A modulator at the dose of 10 mL/kg and 10 mg/kg, respectively on the progression of the epileptogenic process, associated electrophysiological and behavioral arrests, redox stress and neurodegeneration in an animal model of PTZ‐induced generalized epilepsy.